These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15849826)

  • 1. Anti-hepatocarcinoma effects of 5-fluorouracil encapsulated by galactosylceramide liposomes in vivo and in vitro.
    Jin Y; Li J; Rong LF; Li YH; Guo L; Xu SY
    World J Gastroenterol; 2005 May; 11(17):2643-6. PubMed ID: 15849826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.
    Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY
    Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
    Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
    World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
    Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
    Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survivin antisense oligodeoxynucleotides inhibits the proliferation of hepatocellular carcinoma cells and enhances 5-FU sensitivity].
    Wu FY; Huang GS; Jiang JW; Wang F; Xu XD; Peng DY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):304-7. PubMed ID: 20159707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.
    Fanciullino R; Giacometti S; Aubert C; Fina F; Martin PM; Piccerelle P; Ciccolini J
    Pharm Res; 2005 Dec; 22(12):2051-7. PubMed ID: 16222443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
    Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
    J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
    Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G
    Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of 5-fluorouracil encapsulated in amphiphilic polysaccharide nano-micelles and its killing effect on hepatocarcinoma cell line HepG2].
    Zhou JJ; Chen RF; Tang QB; Zhou QB; Lu HW; Wang J
    Ai Zheng; 2006 Dec; 25(12):1459-63. PubMed ID: 17166367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
    Huang Z; Guo KJ; Guo RX; He SG
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
    Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survivin antisense oligodeoxynucleotides inhibits the proliferation of hepatocellular carcinoma cells and enhances the cell chemosensitivity to 5-Fu].
    Wu FY; Huang GS; Jiang JW; Wang F; Xu XD; Peng DY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2251-4. PubMed ID: 19923081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.
    Zhang X; Zhong JL; Liu W; Gao Z; Xue X; Yue P; Wang L; Zhao C; Xu W; Qu X
    Cancer Chemother Pharmacol; 2010 May; 66(1):11-9. PubMed ID: 19756602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of resveratrol and in combination with 5-FU on murine liver cancer.
    Wu SL; Sun ZJ; Yu L; Meng KW; Qin XL; Pan CE
    World J Gastroenterol; 2004 Oct; 10(20):3048-52. PubMed ID: 15378791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis.
    Dun J; Chen X; Gao H; Zhang Y; Zhang H; Zhang Y
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1672-81. PubMed ID: 25736303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
    Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
    J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
    Ghosh S; Pal A; Ray M
    Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
    Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
    Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.